A variation at position -30 of the β-cell glucokinase gene promoter is associated with reduced β-cell function in middle-aged Japanese-American men

Diabetes

Volumn 45, Issue 4, 1996, Pages 422-428

  Stone, Lisa M ^a,b   Kahn, Steven E ^a,b   Fujimoto, Wilfred Y ^a   Deeb, Samir S ^a   Porte Jr , Daniel ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOKINASE; GLUCOSE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HUMAN; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEIC ACID BASE SUBSTITUTION; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0029933511     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.4.422     Document Type: Article

References (43)

1. Porte D Jr: β-cells in type II diabetes mellitus. Diabetes 40:106-180, 1991
2. Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus Am J Physiol 243:E15-E30, 1982
3. Best JD, Judzewitsch RG, Pfeifer MA, Beard JC, Halter JB, Porte D Jr: The effect of chronic sulfonylurea therapy on hepatic glucose production in non-insulin-dependent diabetes. Diabetes 31:333-338, 1982
4. Barnett AH, Eff C, Leslie RD, Pyke DA: Diabetes in identical twins: a study of 200 pairs. Diabetologia 20:87-93, 1981
5. Matschinsky FM: Glucokinase as glucose sensor and metabolic signal generator in pancreatic β-cell and hepatocytes Diabetes 39:647-652, 1990
6. Froguel P, Zouali H, Vionnet N, Velho G, Vaxiliaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokmase. definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702, 1993
7. Chiu KC, Province MA, Permutt MA: Glucokinase gene is genetic marker for NIDDM in American blacks. Diabetes 41:843 849, 1092
8. Chiu KC, Province MA, Dowse GK, Zimmet PZ, Wagner G, Serjeantson S, Permutt MA: A genetic marker at the glucokinase gene locus for Type 2 (non-insulin-dependent) diabetes mellitus in Mauritian Creoles, Diabetologia 35:632-638, 1992
9. McCarthy MI, Hitman GA, Hitchins M, Riikonen A, Stengård J, Nissinen A, Tuomilehto-Wolf E, Tuomilehto J: Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men. Diabetic Med 11.198-204, 1994
10. Noda K, Matsutani A, Tanizawa Y, Neuman R, Kaneko T, Permutt MA, Kaku K: Polymorphic microsatellite repeat markers at the glucokinase gene locus are positively associated with NIDDM in Japanese. Diabetes 42:1147-1152, 1993
11. Chiu KC, Tanizawa Y, Permutt MA: Glucokinase gene variants in the common form of NIDDM. Diabetes 42:579-582, 1993
12. Eto K, Sakura H, Shimokawa K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Kadowaki T: Sequence variations of the glucokinase gene in Japanese subjects with NIDDM. Diabetes 42:1133-1137, 1993
13. Nishi S, Hinata S, Matsukage T, Takeda J, Ichiyama A, Bell GI, Yoshimi T: Mutations in the glucokinase gene are not a major cause of late-onset type 2 (non-insulin-dependent) diabetes mellitus in Japanese subjects. Diabetic Med 11:193-197, 1994
14. Laakso M, Malkki M, Kekalainen P, Kuusisto J, Mykkänen L, Deeb SS: Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance. Diabetes Care 18:398-400, 1995
15. Stone LM, Kahn SE, Deeb SS, Fujimoto WY, Porte D Jr: Glucokinase gene variations in Japanese-Americans with a family history of NIDDM. Diabetes Care 17:1480-1483, 1994
16. Zouali H, Vaxillaire M, Lesage S, Sun F, Velho G, Vionnet N, Chiu K, Passa P, Permutt MA, Demenais F, Cohen D, Beckmann JS, Froguel P: Linkage analysis and molecular scanning of glucokinase gene in NIDDM farrulies. Diabetes 42:1238-1245, 1993
17. Chiu KC, Go RCP, Aoki M, Riggs AC, Tanizawa Y, Acton RT, Bell DSH, Goldenberg RL, Roseman JM, Permutt MA: Glucokinase gene in gestational diabetes mellitus: population association study and molecular scanning. Dialietologia 37:104-110, 1994
18. Elbein SC, Huffman M, Qin H, Chiu K, Tanizawa Y, Permutt MA: Molecular screening of the glucokinase gene in familial type 2 (noninsulin-dependent) diabetes mellitus. Diahetologia 37:182-187, 1994
19. Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Shuman WP, Stolov WC, Wahl PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721-729, 1987
20. Yudkin JS, Alberti KGM, McCarty DG, Swai ABM: Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag? Br Med J 301:397-402, 1990
21. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations., J Clin Invest 93:1130-1130, 1994
22. Yki-Jarvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992
23. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T: Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770, 1989
24. Seltzer HS, Alien WE, Herron AL Jr, Brennan MT Insulin secretion in response to glycemie stimulus: relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46:323-335, 1967
25. Kosaka K, Hagura R, Kuzuya T: Insulin responses in equivocal and definite diabetes, with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Dtabetes 26:944-952, 1977
26. Phillips DIW, Clark PM, Hales CN, Osmond C, Understanding oral glucose tolerance: comparison of glucose or insulin measurement during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabetic Med 11:286-292, 1994
27. Olefsky J, Farquhar JW, Reaven G: Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 22:507-513, 1973
28. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwanz MW, Nciflng JL, Ward WK, Beard JC, Palmer JP, Porte D Jr: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects: evidence for a hyperbolic function Diabetes 42 1663-1672, 1993
29. Thompson EA, Deeb S, Walker D, Motulsky AG: The detection of luikage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. Am J Hum Genet 42:113-124, 1988
30. Hill WG: Estimation of linkage disequilibrium in randomly mating populations. Heredity 33:229-239, 1974
31. Shimokawa K, Sakura H, Otabe S, Eto K, Kadowaki H, Hagura R, Yazaki Y, Akanuma Y, Kadowaki T. Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-crepwident diabetes mellitus. J. Clin Endocrinol Metab 79:883-886, 1994
32. Janssen RC, Bogardus C, Takeda J, Knowler WC, Thompson DB: Linkage analysis of acute insulin secretion with GLUT2 and glucokinase in Pima Indians and the identification of a missense mutation in GLUT2. Diabetes 42:558-563, 1994
33. Kaku K, Matsutani A, Tanizawa Y, Kaneko T, Permutt MA: Structural and promoter mutations responsible for NIDDM. in Proceedings of the 15th International Diabetes Federation Congress, Kobe, Japan, 1994, p 37
34. Mitrakou A, Kelley D, Mokan M, Venemen T, Pangburn T, Rielly J, Gerich J: Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. N Engl J Med 326:22-29, 1992
35. Pimenta W, Korytkowski M, Mitrakou A, Jenssen T, Yki-Jarvinen H, Evron W, Dailey G, Gerich J: Pancreatic beta-cell dysfunction as the primary genetic lesion in NIDDM: evidence from studies m normal glucose-tolerant individuals with a first-degree NIDDM relative. JAMA 273:1855-1861, 1995
36. Creutzfeldt W, Ebert R: New development in the incretin concept Diabetologia 28:565-573, 1985
37. Strubbe JH, Steffens AB: Neural control of insulin secretion. Harm Metnh Res 25:507-512, 1993
38. Cerasi E, Luft R: The plasma insulin response to glucose infusion in healthy subjects and in diabetes mellitus. Acta Endocrinol 55:278-304, 1967
39. Efendic S, Luft R, Wiyngot A: Aspects of the pathogenesis of type 2 diabetes. Endocr Rev 5:395-410, 1984
40. Shelton KD, Franklin AJ, Khoor A, Beechem J, Magnuson M: Multiple elements in the upstream glucokinase promoter contribute to transcription in insulinoma cells. Mol Cell Biol 12:4578-4589, 1992
41. Matsutani A, Noda K, Tao T, Tanizawa Y, Kaneko T, Kaku K: Variation of promoter activity of glucokinase gene in human (Abstract). Diabetes 42 (Suppl. 1):94A, 1993
42. Magnuson MA, Jetton TL: Evolutionary conservation of element in the upstream glucokinase promoter. Biochem Soc Trans 21:160-163, 1993
43. Chen M, Bergman RN, Pacini G, Porte D Jr: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased β-cell function. J Clin Endocritnot Metab 60:13-20, 1985